Back

Complete revascularization strategy in patients with cardiogenic shock due to acute myocardial infarction: insights from the REGALIAM registry

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk stratification and prognostication in acute cardiac care Cardiogenic Shock ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Andre Gonzalez Garcia

Hospital Universitario Alvaro Cunqueiro, Vigo (Spain)

4 More presentations in this session

Presentation thumbnail
Predictors of mortality in patients with cardiogenic shock and veno-arterial extracorporeal membrane oxygenation
Associate Professor M. Laimoud (Riyadh, SA)
Abstract Slides Video
Presentation thumbnail
Impact of chronic kidney disease on clinical outcomes after cardiac surgery
Associate Professor M. Laimoud (Riyadh, SA)
Abstract Slides Video
Presentation thumbnail
Simplified acute physiology score ii to predict hospital mortality among ST-elevation myocardial infarction patients in Switzerland
Ms L. Berther (St. Gallen, CH)
Abstract Slides Video
Presentation thumbnail
Parameters for better stratifying intermediate-high risk patients affected by acute pulmonary embolism
Doctor C. Colombo (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification and prognostication in acute cardiac care

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Complete vs culprit-lesion-only myocardial revascularization in patients with out-of-hospital cardiac arrest: insights from the multicentric "Lombardia CARe" registry
thumbnail
Congress Presentation
Revascularisation after discharge in patients with acute myocardial infarction complicated by cardiogenic shock
thumbnail
Congress Presentation
Percutaneous coronary revascularisation in multivessel disease associated with NSTE-ACS: what is the ideal strategy?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources